Global Biopharma CEOs Frustrated By IP Waiver Talk Amid COVID-19 Vaccine Glut

 
• By Vibha Sharma
  
Businessman holding a foldable smartphone with INTELLECTUAL PROPERTY inscription
IP proposal seeks to waive certain provisions of the TRIPS agreement on COVID-19 products • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from International

More from Geography